StockMarketWire.com - Citigroup today reaffirms its buy investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 10000p (from 7000p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk